Traditional medicine practices among community members with chronic kidney disease in northern Tanzania: an ethnomedical survey

BMC Nephrology

Uptal D. Patel⁴  Justin Omolo³  Venance Maro¹  Francis Karia¹  David Boyd²  Joseph Lunyera²  John W. Stanifer² 

[1] Kilimanjaro Christian Medical College, Moshi, Tanzania, Africa;Duke Global Health Institute, Duke University, Durham, NC, USA;National Institute for Medical Research, Dar es Salaam, Tanzania, Africa;Duke Clinical Research Institute, Duke University, Durham, NC, USA

关键词: Sub-Saharan Africa;    Non-communicable diseases;    Herbal medicine;    Ethnopharmacology;    Epidemiology;   

Others  :  1231146
DOI  :  10.1186/s12882-015-0161-y

 received in 2015-07-16, accepted in 2015-10-09,  发布年份 2015

【 摘 要 】

Background

In sub-Saharan Africa, chronic kidney disease (CKD) is being recognized as a non-communicable disease (NCD) with high morbidity and mortality. In countries like Tanzania, people access many sources, including traditional medicines, to meet their healthcare needs for NCDs, but little is known about traditional medicine practices among people with CKD. Therefore, we sought to characterize these practices among community members with CKD in northern Tanzania.

Methods

Between December 2013 and June 2014, we administered a previously-developed survey to a random sample of adult community-members from the Kilimanjaro Region; the survey was designed to measure traditional medicine practices such as types, frequencies, reasons, and modes. Participants were also tested for CKD, diabetes, hypertension, and HIV as part of the CKD-AFRiKA study. To identify traditional medicines used in the local treatment of kidney disease, we reviewed the qualitative sessions which had previously been conducted with key informants.

Results

We enrolled 481 adults of whom 57 (11.9 %) had CKD. The prevalence of traditional medicine use among adults with CKD was 70.3 % (95 % CI 50.0–84.9 %), and among those at risk for CKD (n = 147; 30.6 %), it was 49.0 % (95 % CI 33.1–65.0 %). Among adults with CKD, the prevalence of concurrent use of traditional medicine and biomedicine was 33.2 % (11.4–65.6 %). Symptomatic ailments (66.7 %; 95 % CI 17.3–54.3), malaria/febrile illnesses (64.0 %; 95 % CI 44.1–79.9), and chronic diseases (49.6 %; 95 % CI 28.6–70.6) were the most prevalent uses for traditional medicines. We identified five plant–based traditional medicines used for the treatment of kidney disease: Aloe vera, Commifora africana, Cymbopogon citrullus, Persea americana, and Zanthoxylum chalybeum.

Conclusions

The prevalence of traditional medicine use is high among adults with and at risk for CKD in northern Tanzania where they use them for a variety of conditions including other NCDs. Additionally, many of these same people access biomedicine and traditional medicines concurrently. The traditional medicines used for the local treatment of kidney disease have a variety of activities, and people with CKD may be particularly vulnerable to adverse effects. Recognizing these traditional medicine practices will be important in shaping CKD treatment programs and public health policies aimed at addressing CKD.

【 授权许可】

   
2015 Stanifer et al.

【 参考文献 】

• [1]Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007; 370(9603):1929-38.
• [2]Unwin N, Setel P, Rashid S, Mugusi F, Mbanya JC, Kitange H et al.. Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda? Bull World Health Organ. 2001; 79(10):947-53.
• [3]Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S et al.. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2014; 2(3):e174-81.
• [4]Stanifer JW, Maro V, Egger J, Karia F, Thielman N, Turner EL et al.. The epidemiology of chronic kidney disease in northern Tanzania: a population-based survey. PLoS One. 2015; 10(4):e0124506.
• [5]Stanifer JW, Patel UD, Karia F, Thielman N, Maro V, Shimbi D et al.. The determinants of traditional medicine use in northern Tanzania: a mixed-methods study. PLoS One. 2015; 10(4):e0122638.
• [6]Colson CR, De Broe ME. Kidney injury from alternative medicines. Adv Chronic Kidney Dis. 2005; 12(3):261-75.
• [7]Isnard Bagnis C, Deray G, Baumelou A, Le Quintrec M, Vanherweghem JL. Herbs and the kidney. Am J Kidney Dis. 2004; 44(1):1-11.
• [8]United Republic of Tanzania: 2012 Population and Housing Census. Dar es Salaam: Central Census Office and National Bureau of Statistics; 2013
• [9]Shen T, Li GH, Wang XN, Lou HX. The genus Commiphora: a review of its traditional uses, phytochemistry and pharmacology. J Ethnopharmacol. 2012; 142(2):319-30.
• [10]Gold CH. Acute renal failure from herbal and patent remedies in Blacks. Clin Nephrol. 1980; 14(3):128-34.
• [11]Luyckx VA, Ballantine R, Claeys M, Cuyckens F, Van den Heuvel H, Cimanga RK et al.. Herbal remedy-associated acute renal failure secondary to Cape aloes. Am J Kidney Dis. 2002; 39(3): Article ID e13
• [12]Ekpenyong CE, Daniel NE, Antai AB. Effect of lemongrass tea consumption on estimated glomerular filtration rate and creatinine clearance rate. J Ren Nutr. 2015; 25(1):57-66.
• [13]Wabuyele E, Kyalo S. Sustainable Use of East African ALoes: The Case of Commerial Aloes in Kenya. International Workshop on the Convention of International Trade in Endangered Species of Wild Fauna and Flora; Cancun, Mexico2008.
• [14]Eshun K, He Q. Aloe vera: a valuable ingredient for the food, pharmaceutical and cosmetic industries--a review. Crit Rev Food Sci Nutr. 2004; 44(2):91-6.
• [15]Mahomoodally MF. Traditional medicines in Africa: an appraisal of ten potent african medicinal plants. Evid Based Complement Alternat Med. 2013; 2013:617459.
• [16]Chen W, Van Wyk B-E, Vermaak I, Viljoen AM. Cape aloes—a review of the phytochemistry, pharmacology and commercialisation of aloe ferox. Phytochem Lett. 2012; 5(1):1-12.
• [17]Nanyingi MO, Mbaria JM, Lanyasunya AL, Wagate CG, Koros KB, Kaburia HF et al.. Ethnopharmacological survey of Samburu district, Kenya. J Ethnobiol Ethnomed. 2008; 4:14. BioMed Central Full Text
• [18]Vogler BK, Ernst E. Aloe vera: a systematic review of its clinical effectiveness. Br J Gen Pract. 1999; 49(447):823-8.
• [19]Grade JT, Tabuti JR, Van Damme P. Ethnoveterinary knowledge in pastoral Karamoja, Uganda. J Ethnopharmacol. 2009; 122(2):273-93.
• [20]Paraskeva MP, van Vuuren SF, van Zyl RL, Davids H, Viljoen AM. The in vitro biological activity of selected South African Commiphora species. J Ethnopharmacol. 2008; 119(3):673-9.
• [21]Ezekiel IMM, Ayo JO, Goji ADT, Okpanachi AO, Mohammed A, Tanko Y. Study of the effect of hydro-ethanolic extract of commiphora Africana (stem-bark) on sleeping time and convulsion in mice. Asian J Med Sci. 2010; 2(3):85-8.
• [22]Kokwaro JO. Medical plants of East Africa. Kampala, Nairobi, Dar es Salaam: East African LIterature Bureau; 1976.
• [23]Lemenih M, Abebe T, Olsson M. Gum and resin resources from some Acacia, Boswellia and Commiphora species and their economic contributions in Liban, south-east Ethiopia. J Arid Environ. 2003; 55(3):465-82.
• [24]Carlini EA, Contar JP, Silva-Filho AR, da Silveira-Filho NG, Frochtengarten ML, Bueno OF. Pharmacology of lemongrass (Cymbopogon citratus Stapf): effects of teas prepared from the leaves on laboratory animals. J Ethnopharmacol. 1986; 17(1):37-64.
• [25]Shah G, Shri R, Panchal V, Sharma N, Singh B, Mann AS. Scientific basis for the therapeutic use of Cymbopogon citratus, stapf (Lemon grass). J Adv Pharm Technol Res. 2011; 2(1):3-8.
• [26]Maia MF, Moore SJ. Plant-based insect repellents: a review of their efficacy, development and testing. Malar J. 2011; 10:S11. BioMed Central Full Text
• [27]Boaduo NK, Katerere D, Eloff JN, Naidoo V. Evaluation of six plant species used traditionally in the treatment and control of diabetes mellitus in South Africa using in vitro methods. Pharm Biol. 2014; 52(6):756-61.
• [28]Dike IP, Obembe OO, Adebiyi FE. Ethnobotanical survey for potential anti-malarial plants in south-western Nigeria. J Ethnopharmacol. 2012; 144(3):618-26.
• [29]Fandohan P, Gnonlonfin B, Laleye A, Gbenou JD, Darboux R, Moudachirou M. Toxicity and gastric tolerance of essential oils from Cymbopogon citratus, Ocimum gratissimum and Ocimum basilicum in Wistar rats. Food Chem Toxicol. 2008; 46(7):2493-7.
• [30]Adeneye AA, Agbaje EO. Hypoglycemic and hypolipidemic effects of fresh leaf aqueous extract of Cymbopogon citratus Stapf. in rats. J Ethnopharmacol. 2007; 112(3):440-4.
• [31]Musabayane CT. The effects of medicinal plants on renal function and blood pressure in diabetes mellitus. Cardiovasc J Afr. 2012; 23(8):462-8.
• [32]Ojewole JA, Kamadyaapa DR, Gondwe MM, Moodley K, Musabayane CT. Cardiovascular effects of Persea americana Mill (Lauraceae) (avocado) aqueous leaf extract in experimental animals. Cardiovasc J Afr. 2007; 18(2):69-76.
• [33]Yasir M, Das S, Kharya MD. The phytochemical and pharmacological profile of Persea americana Mill. Pharmacogn Rev. 2010; 4(7):77-84.
• [34]Rodriguez-Sanchez DG, Flores-Garcia M, Silva-Platas C, Rizzo S, Torre-Amione G, De la Pena-Diaz A et al.. Isolation and chemical identification of lipid derivatives from avocado (Persea americana) pulp with antiplatelet and antithrombotic activities. Food Funct. 2015; 6(1):193-203.
• [35]Ojewole JA, Amabeoku GJ. Anticonvulsant effect of Persea americana Mill (Lauraceae) (Avocado) leaf aqueous extract in mice. Phytother Res. 2006; 20(8):696-700.
• [36]Adeyemi OO, Okpo SO, Ogunti OO. Analgesic and anti-inflammatory effects of the aqueous extract of leaves of Persea americana mill (lauraceae). Fitoterapia. 2002; 73(5):375-80.
• [37]Karou SD, Tchacondo T, Djikpo Tchibozo MA, Abdoul-Rahaman S, Anani K, Koudouvo K et al.. Ethnobotanical study of medicinal plants used in the management of diabetes mellitus and hypertension in the Central Region of Togo. Pharm Biol. 2011; 49(12):1286-97.
• [38]Tabuti JR, Kukunda CB, Waako PJ. Medicinal plants used by traditional medicine practitioners in the treatment of tuberculosis and related ailments in Uganda. J Ethnopharmacol. 2010; 127(1):130-6.
• [39]Lim T. Edible Medicinal and Non-Medical Plants. Springer, New York; 2012.
• [40]Gessler MC, Msuya DE, Nkunya MH, Mwasumbi LB, Schar A, Heinrich M et al.. Traditional healers in Tanzania: the treatment of malaria with plant remedies. J Ethnopharmacol. 1995; 48(3):131-44.
• [41]Chisowa EH, Hall DR, Farman DI. Volatile constituents of the leaf oil of Zanthoxylum chalybeum Engl. J Essent Oil Res. 1999; 11(3):360-2.
• [42]Engeu OP, Tumusiime RH, Agwaya M, Mugisha G, Nambatya GK, Galiwango M, Waako P. Repeat-dose effects of Zanthoxylum chalybeum root bark extract: a traditional medicinal plant used for various diseases in Uganda. African J Pharm Pharmacol. 2008; 2(6):101-5.
• [43]Kokwaro J. Rutuceae. Flora of Tropical East Arica. PolHill RM, editor. AA Balkema, Rotterdam; 1982.
• [44]Roberts MFW. Alkaloids: Biochemistry, Ecology and Medicinal Applications. Plenum Press, New York; 1998.
• [45]Olila D, Olwa O, Opuda-Asibo J. Screening extracts of Zanthoxylum chalybeum and Warburgia ugandensis for activity against measles virus (Swartz and Edmonston strains) in vitro. Afr Health Sci. 2002; 2(1):2-10.
• [46]Musila MF, Dossaji SF, Nguta JM, Lukhoba CW, Munyao JM. In vivo antimalarial activity, toxicity and phytochemical screening of selected antimalarial plants. J Ethnopharmacol. 2013; 146(2):557-61.
• [47]Ocheng F, Bwanga F, Joloba M, Borg-Karlson AK, Gustafsson A, Obua C. Antibacterial activities of extracts from Ugandan medicinal plants used for oral care. J Ethnopharmacol. 2014; 155(1):852-5.
• [48]Gessler MC, Nkunya MH, Mwasumbi LB, Heinrich M, Tanner M. Screening Tanzanian medicinal plants for antimalarial activity. Acta Trop. 1994; 56(1):65-77.